John O'Donnell is a notable inventor based in Mattapoisett, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as beta-lactamase inhibitors. His work is crucial in addressing bacterial infections, especially those caused by drug-resistant organisms.

Latest Patents

O'Donnell holds a patent for beta-lactamase inhibitor compounds. The present invention is directed to compounds which are beta-lactamase inhibitors. These compounds and their pharmaceutically acceptable salts are useful in combination with beta-lactam antibiotics for the treatment of bacterial infections, including those caused by multi-drug resistant organisms. The invention includes compounds according to Formula (I) or a pharmaceutically acceptable salt thereof, wherein the values of R, R, R, R, R, and R are described in the patent documentation. He has 1 patent to his name.

Career Highlights

John O'Donnell is currently associated with Entasis Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments for challenging bacterial infections.

Collaborations

O'Donnell collaborates with talented professionals in his field, including Janelle Comita-Prevoir and Thomas Francois Durand-Reville. Their combined expertise contributes to the advancement of research and development in pharmaceuticals.

Conclusion

John O'Donnell's contributions to the field of beta-lactamase inhibitors highlight his role as an important inventor in the pharmaceutical industry. His work is vital in the ongoing battle against drug-resistant bacterial infections.

Profile summary based on public USPTO records.